Syndecan-1 as a biomarker for sepsis survival after major abdominal surgery

Biomark Med. 2018 Feb;12(2):119-127. doi: 10.2217/bmm-2017-0231. Epub 2018 Jan 12.

Abstract

Aim: Sepsis is a serious complication following surgery and identification of patients at risk is of high importance. Syndecan-1 (sSDC1) levels are known to be elevated during sepsis.

Materials & methods: Fifty-five patients scheduled for major abdominal surgery were prospectively included and sSDC1 concentrations were measured during hospital stay.

Results: Patients with postoperative sepsis showed a continued increase of sSDC1 levels and exhibited higher median sSDC1 concentrations at day 1 compared with nonseptic patients 90.3 versus 16.5 ng/ml. A significant association of sSDC1 levels with the incidence of sepsis and death was demonstrated.

Conclusion: This study identifies sSDC1 as potential biomarker for sepsis and survival after abdominal surgery.

Keywords: biomarker; endothelium; glycocalyx; sepsis; shedding; syndecan-1.

MeSH terms

  • Abdomen / surgery*
  • Aged
  • Area Under Curve
  • Biomarkers / blood*
  • C-Reactive Protein / analysis
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Intensive Care Units
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Postoperative Complications
  • Prospective Studies
  • ROC Curve
  • Sepsis / diagnosis*
  • Sepsis / etiology
  • Sepsis / mortality
  • Syndecan-1 / blood*

Substances

  • Biomarkers
  • Syndecan-1
  • C-Reactive Protein